2CN.F · Harvest One Cannabis Inc

-

Please sign in to comment on 2CN.F

1 Comment

Admin

3 years, 7 months ago

Harvest One Cannabis Inc is currently in a long term downtrend where the price is trading 20.4% below its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.

Harvest One Cannabis Inc's total revenue rose by 9.5% to $2M since the same quarter in the previous year.

Its net income has increased by 10.7% to $-14M since the same quarter in the previous year.

Finally, its free cash flow grew by 41.1% to $-4M since the same quarter in the previous year.

Based on the above factors, Harvest One Cannabis Inc gets an overall score of 4/5.

Industry	Drug Manufacturers-Specialty & Generic
ISIN	None
Sector	Healthcare
CurrencyCode	EUR
Exchange	F

Market Cap	9M
PE Ratio	None
Dividend Yield	0.0%
Target Price	None
Beta	1.77

ABOUT

Harvest One Cannabis Inc

Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. It operates through two segments, Medical and Nutraceutical, and Consumer. The Medical and Nutraceutical segment is involved in the processing, manufacturing, and distribution of cannabis-based food supplement products. The Consumer segment engages in the marketing, distribution, and product development of liquid sleep shots and sleep powder packets, as well as pain relief creams. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada.

2CN.F · Harvest One Cannabis Inc

-

Harvest One Cannabis Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Harvest One Cannabis Inc using a moving average strategy